256 related articles for article (PubMed ID: 8791962)
1. High-dose ranitidine for the prevention of recurrent peptic ulcer disease in rheumatoid arthritis patients taking NSAIDs.
ten Wolde S; Dijkmans BA; Janssen M; Hermans J; Lamers CB
Aliment Pharmacol Ther; 1996 Jun; 10(3):347-51. PubMed ID: 8791962
[TBL] [Abstract][Full Text] [Related]
2. Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine.
Ehsanullah RS; Page MC; Tildesley G; Wood JR
BMJ; 1988 Oct; 297(6655):1017-21. PubMed ID: 3142593
[TBL] [Abstract][Full Text] [Related]
3. The effect of ranitidine on NSAID related dyspeptic symptoms with and without peptic ulcer disease of patients with rheumatoid arthritis and osteoarthritis.
Van Groenendael JH; Markusse HM; Dijkmans BA; Breedveld FC
Clin Rheumatol; 1996 Sep; 15(5):450-6. PubMed ID: 8894357
[TBL] [Abstract][Full Text] [Related]
4. Ranitidine in the treatment of non-steroidal anti-inflammatory drug associated gastric and duodenal ulcers.
Lancaster-Smith MJ; Jaderberg ME; Jackson DA
Gut; 1991 Mar; 32(3):252-5. PubMed ID: 2013419
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori and nonsteroidal anti-inflammatory drugs: interaction with proton pump inhibitor therapy for prevention of nonsteroidal anti-inflammatory drug ulcers and ulcer complications--future research needs.
Graham DY
Am J Med; 2001 Jan; 110(1A):58S-61S. PubMed ID: 11166000
[TBL] [Abstract][Full Text] [Related]
6. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients.
Bianchi Porro G; Lazzaroni M; Petrillo M
Am J Gastroenterol; 1997 Apr; 92(4):663-7. PubMed ID: 9128319
[TBL] [Abstract][Full Text] [Related]
7. Progress in prophylaxis against nonsteroidal anti-inflammatory drug-associated ulcers and erosions. Omeprazole NSAID Steering Committee.
Hawkey CJ
Am J Med; 1998 Mar; 104(3A):67S-74S; discussion 79S-80S. PubMed ID: 9572324
[TBL] [Abstract][Full Text] [Related]
8. New data on healing of nonsteroidal anti-inflammatory drug-associated ulcers and erosions. Omeprazole NSAID Steering Committee.
Yeomans ND
Am J Med; 1998 Mar; 104(3A):56S-61S; discussion 79S-80S. PubMed ID: 9572322
[TBL] [Abstract][Full Text] [Related]
9. Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in longterm NSAID users. Response to omeprazole dual therapy.
Bianchi Porro G; Parente F; Imbesi V; Montrone F; Caruso I
Gut; 1996 Jul; 39(1):22-6. PubMed ID: 8881802
[TBL] [Abstract][Full Text] [Related]
10. [Ulcer healing with ranitidine and antacids despite continued therapy with non-steroidal anti-rheumatic drugs].
Stock KP; Bach GL
Z Rheumatol; 1988; 47(3):177-81. PubMed ID: 3213266
[TBL] [Abstract][Full Text] [Related]
11. Misoprostol and ranitidine in the prevention of NSAID-induced ulcers: a prospective, double-blind, multicenter study.
Raskin JB; White RH; Jaszewski R; Korsten MA; Schubert TT; Fort JG
Am J Gastroenterol; 1996 Feb; 91(2):223-7. PubMed ID: 8607484
[TBL] [Abstract][Full Text] [Related]
12. Critical effect of Helicobacter pylori infection on the effectiveness of omeprazole for prevention of gastric or duodenal ulcers among chronic NSAID users.
Graham DY
Helicobacter; 2002 Feb; 7(1):1-8. PubMed ID: 11886469
[TBL] [Abstract][Full Text] [Related]
13. Superiority of lansoprazole vs ranitidine in healing nonsteroidal anti-inflammatory drug-associated gastric ulcers: results of a double-blind, randomized, multicenter study. NSAID-Associated Gastric Ulcer Study Group.
Agrawal NM; Campbell DR; Safdi MA; Lukasik NL; Huang B; Haber MM
Arch Intern Med; 2000 May; 160(10):1455-61. PubMed ID: 10826458
[TBL] [Abstract][Full Text] [Related]
14. Effect of H. pylori status on gastric ulcer healing in patients continuing nonsteroidal anti-inflammatory therapy and receiving treatment with lansoprazole or ranitidine.
Campbell DR; Haber MM; Sheldon E; Collis C; Lukasik N; Huang B; Goldstein JL
Am J Gastroenterol; 2002 Sep; 97(9):2208-14. PubMed ID: 12358234
[TBL] [Abstract][Full Text] [Related]
15. Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs.
Taha AS; Hudson N; Hawkey CJ; Swannell AJ; Trye PN; Cottrell J; Mann SG; Simon TJ; Sturrock RD; Russell RI
N Engl J Med; 1996 May; 334(22):1435-9. PubMed ID: 8618582
[TBL] [Abstract][Full Text] [Related]
16. Neutrophils, Helicobacter pylori, and nonsteroidal anti-inflammatory drug ulcers.
Taha AS; Dahill S; Morran C; Hudson N; Hawkey CJ; Lee FD; Sturrock RD; Russell RI
Gastroenterology; 1999 Feb; 116(2):254-8. PubMed ID: 9922304
[TBL] [Abstract][Full Text] [Related]
17. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
Goldstein JL; Huang B; Amer F; Christopoulos NG
Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
[TBL] [Abstract][Full Text] [Related]
18. Is ranitidine therapy sufficient for healing peptic ulcers associated with non-steroidal anti-inflammatory drug use?
Yeomans ND; Svedberg LE; Naesdal J
Int J Clin Pract; 2006 Nov; 60(11):1401-7. PubMed ID: 17073837
[TBL] [Abstract][Full Text] [Related]
19. Ranitidine bismuth citrate plus clarithromycin is effective for healing duodenal ulcers, eradicating H. pylori and reducing ulcer recurrence. RBC H. pylori Study Group.
Peterson WL; Ciociola AA; Sykes DL; McSorley DJ; Webb DD
Aliment Pharmacol Ther; 1996 Jun; 10(3):251-61. PubMed ID: 8791947
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of ranitidine 150 mg at bedtime as maintenance therapy for healed gastric ulcers.
Sue SO; Dawson DM; Brown JA; Wood DR; Kleoudis CS
Clin Ther; 1996; 18(6):1175-83. PubMed ID: 9001834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
